Stockscreener 앱 받기
1.87
2.09%
-0.04
전일 마감가:
$1.91
열려 있는:
$1.92
하루 거래량:
264.28K
Relative Volume:
0.95
시가총액:
$62.37M
수익:
$66.16M
순이익/손실:
$128.94M
주가수익비율:
0.5876
EPS:
3.1823
순현금흐름:
$152.08M
1주 성능:
-12.41%
1개월 성능:
-23.98%
6개월 성능:
-20.43%
1년 성능:
-31.75%
1일 변동 폭
$1.84
$1.925
1주일 범위
$1.84
$2.134
52주 변동 폭
$1.84
$4.53
Fortress Biotech Inc Stock (FBIO) Company Profile
명칭
Fortress Biotech Inc
전화
781-652-4500
주소
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Compare FBIO vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
1.87 | 62.37M | 66.16M | 128.94M | 152.08M | 3.1823 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-15 | 재개 | ROTH MKM | Buy |
| 2022-08-04 | 개시 | Ladenburg Thalmann | Buy |
| 2020-10-02 | 개시 | The Benchmark Company | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2018-02-28 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | 개시 | Rodman & Renshaw | Buy |
| 2017-03-22 | 개시 | JMP Securities | Mkt Outperform |
| 2016-10-03 | 개시 | ROTH Capital | Buy |
모두보기
Fortress Biotech Inc 주식(FBIO)의 최신 뉴스
Fortress Biotech repays USD 15 million debt: what it means for Fortress Biotech stock - ad-hoc-news.de
Fortress Biotech stock gains as USD 15.0 million debt is repaid - ad-hoc-news.de
Fortress Biotech stock fell 1.93 percent on October 2 - ad-hoc-news.de
Fortress Biotech Stock Price Forecast. Should You Buy FBIO? - StockInvest.us
Fortress Biotech Inc (FBIO-Q) Stock Price and News - The Globe and Mail
Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP-Q) Stock Price and News - The Globe and Mail
Fortress Biotech (FBIO) Slips 3.27% to $2.07 as Shares Drift Toward Lower SupportBearish Sentiment - siam.in
Form 8K Fortress Biotech Inc For: 1 October By Investing.com - Investing.com Nigeria
Fortress Biotech repays $15 million Oaktree credit facility in full - Investing.com
Fortress Biotech repays $15 million Oaktree credit facility in full By Investing.com - Investing.com Nigeria
Form 8K Fortress Biotech Inc For: 1 October By Investing.com - Investing.com Canada
Form 8K Fortress Biotech Inc For: 1 October By Investing.com - Investing.com UK
Fortress Biotech repaid $15.0M and terminated Oaktree secured credit facility - TradingView
Through its employee stock purchase plan, Fortress Biotech (FBIO) CFO David Jin acquires 1,190 shares. - stocktitan.net
Fortress Biotech, Inc. Repays Remaining $15 Million Outstanding Principal Under Oaktree Agreement - www.marketscreener.com
CNB0 Bond Profile: Coupon and Redemption - TradingView
Precision Trading with Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) Risk Zones - Stock Traders Daily
Latest Fortress Biotech, Inc.9.375% Series A Cumulative Redeemable Perpetual Preferred Stock news - Securities.io
Precision Trading with Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) Risk Zones - Stock Traders Daily
Fortress Biotech's business presentation goes online Sept. 11 - Stock Titan
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Moomoo
Best Cheap Stocks Under $10 with High Return Potential (September 2026) - Investing.com
Fortress Biotech (FBIO) Rises to $2.73 as Buyers Defend Key Support ZoneWide Range Bar - dars.gov.et
Fortress Biotech (FBIO) Rises to $2.73 as Buyers Defend Key Support ZoneBlue Chip Entry Points - siam.in
Fortress Biotech (FBIO) Rises to $2.73 as Buyers Defend Key Support ZoneRunaway Gap - vinanet.vn
Integrated Core Strategies (US) LLC Discloses 5.3% Stake in Fortress Biotech (NASDAQ: FBIO) via 13G Filing - Kalkine Media
Passive stake disclosed in Fortress Biotech (NASDAQ: FBIO) by Millennium group - Stock Titan
(FBIOP) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Fortress Biotech Inc. (FBIO) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
A. G. P. Maintains Fortress Biotech(FBIO.US) With Buy Rating, Maintains Target Price $5 - Moomoo
FBIO | Fortress Biotech, Inc. FinancialsRevenue Breakdown - Quiver Quantitative
Fortress Biotech (FBIO) Q2 2026 Earnings Call Transcript - AOL.ca
ETFs Investing in Fortress Biotech, Inc. Stocks - TradingView
Fortress Biotech (FBIO) Slips 1.68% to $2.93 as Small-Cap Biotech Faces PressureBollinger Squeeze - vinanet.vn
Fortress Biotech (NASDAQ:FBIO) Lowered to Hold Rating by Wall Street Zen - MarketBeat
Fortress Biotech (FBIO) Pulls Back 3% as Shares Approach Key $2.75 SupportFear Greed Index - vinanet.vn
Fortress Biotech (FBIO) Pulls Back 3% as Shares Approach Key $2.75 SupportATR Stop - dars.gov.et
Fortress Biotech, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Fortress Biotech earnings beat by $0.11, revenue fell short of estimates - Investing.com Canada
Fortress Biotech (NASDAQ:FBIO) Posts Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat
Fortress Biotech: Q2 Earnings Snapshot - marketscreener.com
Fortress Biotech: Q2 Earnings Snapshot - AOL.com
Fortress Biotech: Q2 Earnings Snapshot - KTVB
Fortress Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Fortress Biotech 2026: Revenue $17.84M, Net income ($2.48M), EPS ($0.08) — 10-Q Summary - TradingView
Fortress Biotech (NASDAQ: FBIO) gains $158.9M from voucher sale and boosts cash - Stock Titan
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewswire
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - Yahoo Finance
Fortress Biotech Inc (FBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.22%
자본화:
|
볼륨(24시간):